Nuclear Medicine: Page 164

PiB-PET scans show link between poor sleep and Alzheimer's

By Wayne Forrest

PET scans using the Pittsburgh Compound B (PiB) radiopharmaceutical have shown a potential link between poor sleep and greater beta-amyloid accumulation, which could lead to Alzheimer's disease in older adults, according to a study published online October 21 in JAMA Neurology.

October 21, 2013

PET/CT technique aids in cancer surgery

By AuntMinnie.com staff writers

The use of PET/CT to create 3D images of a patient can help surgeons see detailed anatomical structures and gain better views of a tumor.

October 17, 2013

PET shows link between arterial stiffness and dementia

By Wayne Forrest

PET scans show that elderly people with hardening of the arteries are more likely to have beta-amyloid plaque in the brain, even if they show no signs of dementia or Alzheimer's disease, according to a study published online October 16 in Neurology.

October 16, 2013

Sofie seals $5M in financing

By AuntMinnie.com staff writers

Molecular imaging developer Sofie Biosciences has raised $5 million in financing from a group of investors.

October 14, 2013

Better training key to unlocking molecular imaging's potential

By Wayne Forrest

Molecular imaging has vast potential to improve healthcare in the coming years by allowing more directed, personalized therapy. But molecular imaging's contribution may be limited until more imaging specialists are trained to interpret scans acquired with the new types of tracers being developed.

October 10, 2013

Navidea touts Lymphoseek trial results

By AuntMinnie.com staff writers

Radiopharmaceutical vendor Navidea Biopharmaceuticals is promoting results from a clinical trial of its Lymphoseek imaging agent.

October 10, 2013